ELA
Envela Corporation
ELA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
NKE
NIKE, Inc.
NKE has the edge over ELA overall, supported by stronger valuation and stronger modeled upside.
ELA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Healthy | |
| Strong |
ELA's revenue, profitability, cash flow and balance sheet are all currently healthy.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
ELA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $10.14 | -2.4% |
| Current | 12x | $10.39 | — |
| Fair | 18x | $15.50 | +49% |
| Forward | 19x | $10.39 | — |
| Expensive | 30x | $25.09 | +141% |
Historical ranges are pointers, not guarantees.
ELA's PE is in its cheap range at 12x. Analysts expect earnings to fall, which would put today's price at 19x next year's earnings, in its fair range.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over ELA in the historical PE scenario, which offers more potential upside but is not a forecast.
ELA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect ELA's earnings and revenue to decline, with profitability weakening.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
NKE has the edge over ELA on the outlook, with more favorable earnings and profitability expectations.
ELA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.56 | -35% |
| Q2 2026 | $0.85 | +150% |
| Q1 2026 | $0.80 | +176% |
| Q4 2025 | $0.56 | +115% |
| Q3 2025 | $0.41 | +64% |
| Q2 2025 | $0.34 | +36% |
| Q1 2025 | $0.29 | +16% |
| Q4 2024 | $0.26 | -3.7% |
| Q3 2024 | $0.25 | -42% |
ELA has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
ELA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $56.8M | +3.5% |
| Q1 2026 | $98.4M | +104% |
| Q4 2025 | $80.5M | +67% |
| Q3 2025 | $57.4M | +22% |
| Q2 2025 | $54.9M | +21% |
| Q1 2025 | $48.3M | +21% |
| Q4 2024 | $48.3M | +32% |
| Q3 2024 | $46.9M | +29% |
ELA has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 9% | +3.1 points |
| Q1 2026 | 11% | +4.9 points |
| Q4 2025 | 9.4% | +5.4 points |
| Q3 2025 | 7.3% | +3 points |
| Q2 2025 | 5.9% | +1.7 points |
| Q1 2025 | 6.5% | +0.6 points |
| Q4 2024 | 3.9% | -0.4 points |
| Q3 2024 | 4.3% | -1.1 points |
ELA has the edge over NKE on profitability, with a higher operating margin.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
ELA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $5M | +137% |
| Q1 2026 | $20.6M | +2658% |
| Q4 2025 | -$3.7M | -215% |
| Q3 2025 | $2.2M | +51% |
| Q2 2025 | $2.1M | +$3.4M |
| Q1 2025 | $746.6K | -78% |
| Q4 2024 | $3.2M | +91% |
| Q3 2024 | $1.5M | +172% |
ELA has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
ELA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -0.1% | -28.5K shares |
| 3 years | -3.6% | -968K shares |
| 5 years | -3.6% | -976K shares |
| Available history | -3.6% | -961K shares |
ELA has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $67,582 |
| Q2 2025 | $118,700 |
| Q1 2025 | $2,626 |
| Q4 2024 | $64,779 |
| Q3 2024 | $728,510 |
| Q2 2024 | $715,339 |
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
ELA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.8x | Net Cash |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
| Q3 2024 | -0.4x | Net Cash |
ELA has the edge over NKE on leverage, with a lower net debt burden relative to earnings.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
ELA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.8 | Oversold |
| Stochastic | 1.6 | Oversold |
ELA's weekly RSI is 30 (oversold) and its Stochastic is 2 (oversold).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
ELA PE vs Consumer Cyclical Sector
| Metric | ELA | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 32% below |
| PE % | 20 | 47 | 27 pts below |
ELA has the edge over NKE on valuation relative to its sector.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
ELA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.5 | 10% below |
| 20 week MA | $15.3 | 32% below |
| 50 week MA | $16.6 | 37% below |
| 100 week MA | $11.8 | 12% below |
| 200 week MA | $8.64 | 20% above |
ELA has fallen below most of its moving averages, though it's still 20% above its 200-week average.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
ELA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.37 | $5.01 | +266% |
| 2021 | $5.01 | $4.10 | -18% |
| 2022 | $4.10 | $5.29 | +29% |
| 2023 | $5.29 | $4.86 | -8.1% |
| 2024 | $4.86 | $7.15 | +47% |
| 2025 | $7.15 | $12.5 | +75% |
| 2026 YTD | $12.5 | $10.4 | -17% |
ELA has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.